Americas · Regional markets · Financial Post

Ferrer and Prilenia Announce Authorization for EU Initiation of Confirmatory PRECISE-HD Study of Pridopidine in Huntington’s Disease

Published by Financial Post · Canada 1 h ago

BARCELONA, Spain — Ferreri and Prilenia Therapeutics B.V. today announced that the confirmatory Phase 3 PRECISE-HD study of investigational pridopidine in Huntington’s disease…

Read the full article on Financial Post Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (financialpost.com)

Also worth reading

BNN Bloomberg

U.S. embassy accuses Canadian politicians of interfering in American elections

Bloomberg Línea

Ni Lula ni Bolsonaro evitarán que Brasil vaya a un ajuste fiscal, según Fitch

Gestión

¿Eres cocinero y hablas español? La vacante para trabajar con Mamdani por US$64,500 anuales

El Cronista

Dólar hoy: a cuánto cotiza el oficial en los bancos de la City hoy jueves 22 de octubre

La República

Ordoñez será ministro del Interior, un cargo que dura 16 meses en promedio

Ámbito